Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 752 All time
- Disclosed funding
- $25.4B 616 disclosed amounts
- Median round
- $15.8M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| S SediventionCompany profile Develops minimally invasive one-time cryoablation therapy for obesity via balloon catheter Develops minimally invasive one-time cryoablation therapy for obesity via balloon catheter | €2.9M | Seed | Healthtech | Germany | Investors | |
| C CellCentricCompany profile Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma Develops inobrodib, a first-in-class oral p300/CBP inhibitor for relapsed or refractory multiple myeloma | $220M | Series DSeries C+ | Healthtech, Biotech | United Kingdom | Investors | |
| M MOSH makes protein bars marketed for brain health. | $13M | Series A | Healthtech, Foodtech | United States | Investors | |
| KB Kanvas BiosciencesCompany profile Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy Develops microbiome-based live biotherapeutics for cancer patients who do not respond to immunotherapy | $48M | Series A | Healthtech, Biotech | United States | Investors | |
| MN Maurice & NoraCompany profile Connects families and seniors with students for non-medical in-home assistance via AI-matched platform Connects families and seniors with students for non-medical in-home assistance via AI-matched platform | €1M | Seed | Healthtech | Belgium | Investors | |
| LT LTZ TherapeuticsCompany profile LTZ Therapeutics develops cancer immunotherapies that target myeloid biology. LTZ Therapeutics develops cancer immunotherapies that target myeloid biology. | $38M | Undisclosed | Healthtech, Biotech | United States | Investors | |
| MP Modicus PrimeCompany profile Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries Builds AI compliance software enabling audit-ready AI deployment for pharmaceutical and regulated industries | $4.5M | Undisclosed | Healthtech | United States | Investors | |
| SB Signadori BioCompany profile Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage Develops in vivo engineered monocyte immunotherapy to treat solid tumours in preclinical stage | €11.1M | Seed+Seed | Healthtech, Biotech | France | Investors | |
| XH XCaliber HealthCompany profile Automates healthcare workflows across EHR, scheduling, and referrals using agentic AI for provider groups Automates healthcare workflows across EHR, scheduling, and referrals using agentic AI for provider groups | $6.5M | Seed | Healthtech | United States | Investors | |
| 4P 4D PathCompany profile Digital biomarkers designed to predict cancer treatment response from routine biopsy images. Digital biomarkers designed to predict cancer treatment response from routine biopsy images. | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors Undisclosed |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.